Brilliant Violet 605™ anti-human TIGIT (VSTM3) | BioLegend 372711 product information

product summary

company name :

BioLegend

other brands :

Babco, Signet, Sternberger Monoclonals, Senetek, Covance

product type :

antibody

product name :

Brilliant Violet 605™ anti-human TIGIT (VSTM3)

catalog :

372711

quantity :

25 tests

price :

215 USD

clonality :

monoclonal

host :

mouse

conjugate :

BV605

clone name :

A15153G

reactivity :

human

application :

flow cytometry

more info or order :

BioLegend product webpage

citations: 9

Published Application/Species/Sample/Dilution	Reference
flow cytometry; human; loading ...; fig s2b	Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
	Metelo A, Jozwik A, Luong L, Dominey Foy D, Graham C, Attwood C, et al. Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors. Cancer Res Commun. 2022;2:158-171 pubmed publisher
	Van Zeebroeck L, Arroyo Hornero R, Côrte Real B, Hamad I, Meissner T, Kleinewietfeld M. Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol. 2021;12:655122 pubmed publisher
	Vitanza N, Johnson A, Wilson A, Brown C, Yokoyama J, K xfc nkele A, et al. Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis. Nat Med. 2021;27:1544-1552 pubmed publisher
	Blache U, Weiss R, Boldt A, Kapinsky M, Blaudszun A, Quaiser A, et al. Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications. Front Immunol. 2021;12:658314 pubmed publisher
	Guo X, Mahlak xf5 iv T, Ye Q, Somanchi S, He S, Rana H, et al. CBLB ablation with CRISPR/Cas9 enhances cytotoxicity of human placental stem cell-derived NK cells for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
	Braun D, Street K, Burke K, Cookmeyer D, Denize T, Pedersen C, et al. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell. 2021;39:632-648.e8 pubmed publisher
	Cella M, Gamini R, Sécca C, Collins P, Zhao S, Peng V, et al. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Nat Immunol. 2019;: pubmed publisher
	Stamm H, Klingler F, Grossjohann E, Muschhammer J, Vettorazzi E, Heuser M, et al. Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option. Oncogene. 2018;37:5269-5280 pubmed publisher

product information

Antigen :

TIGIT

Apps. Abbrev. :

Cat # :

372711

Clone :

A15153G

Item :

Brilliant Violet 605™ anti-human TIGIT (VSTM3)

Isotype :

Mouse IgG2a, κ

Other Names :

T-cell immunoreceptor with Ig and ITIM domains, VSIG9, VSTM3, WUCAM

Size :

25 tests

Price (USD) :

215 USD

Reactivity :

Human

Clonality :

Monoclonal

Host :

Mouse

Conjugate/Tag/Label :

BV605

Immunogen :

Recombinant Human TIGIT.

Application Notes :

This clone can suppress anti-CD3 induced T cell proliferation in vitro based on in-house testing.This clone has been tested in-house and determined to not be suitable for applications in immunohistochemistry of paraffin-embedded tissue sections (IHC-P).Additional reported applications (for the relevant formats) include: Blocking^1.;

more info or order :

BioLegend product webpage